Czechia vs New Zealand: Previously treated cases tested for RR-/MDR-TB
Czechia
58.0%
in 2024
New Zealand
58.0%
in 2014
Czechia rank
140th
New Zealand rank
140th
Previously treated cases tested for RR-/MDR-TB over time
- Czechia
- New Zealand
How they compare
Czechia currently reports 58.0% against 58.0% in New Zealand, a difference of 0.0%.
The two have swapped places 2 times across 9 shared years of data; in 2005 it was New Zealand ahead.
Czechia ranks 140th and New Zealand ranks 140th of 180 countries.
New Zealand has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Czechia | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 57.2% | 69.0% | 11.8% | New Zealand |
| 2010s | 56.0% | 78.0% | 22.0% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Czechia or New Zealand?
- Czechia, at 58.0% against 58.0% in New Zealand as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Czechia and New Zealand?
- 0.0%, with Czechia ahead.
- How many years of comparable data are there for Czechia and New Zealand?
- 9 years are reported by both, from 2005 to 2014.
- How do Czechia and New Zealand rank globally for previously treated cases tested for rr-/mdr-tb?
- Czechia ranks 140th and New Zealand ranks 140th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.